Poolbeg Pharma Plc (POLB)

Cavendish - Morning Note – 30 June 2026

Cavendish - Poolbeg Pharma - POLB 001 patent granted in South Africa

Poolbeg Pharma has received notification of the official decision to grant its Immunomodulator II patent in South Africa, providing protection for...

Poolbeg Pharma PLC POLB 001 patent granted in South Africa

Poolbeg Pharma PLC 30 June 2026     Poolbeg Pharma plc   POLB 001 patent granted in South Africa for the treatment or prevention of...

Cavendish - Morning Note – 16 June 2026

Poolbeg Secures European Patent Grant for POLB 001 Cancer Immunotherapy Programme (POLB)

Poolbeg Pharma (LSE:POLB) has received a decision to grant a European patent covering the use of POLB 001 for the prevention of cancer...

Cavendish - Poolbeg Pharma - European patent grant for POLB 001

Poolbeg Pharma has received formal notification of the decision to grant its POLB 001 cancer immunotherapyinduced Cytokine Release Syndrome (CRS...

Poolbeg Pharma PLC European patent granted for POLB 001 in CRS

Poolbeg Pharma PLC 16 June 2026     Poolbeg Pharma plc   Decision to grant European Patent received for POLB 001 in cancer immunotherapy-induced...

Poolbeg Pharma PLC PDMR Notification

Poolbeg Pharma PLC 16 June 2026     Poolbeg Pharma plc   PDMR Notification   16 June 2026- Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the...

Cavendish - Morning Note – 11 June 2026

Poolbeg Pharma Reaches Key Clinical Milestone as POLB 001 Trial Begins Patient Recruitment

Poolbeg Pharma (LSE:POLB) has activated the first clinical trial site and started recruiting patients for its first-in-patient POLB 001 TOPICAL...

Cavendish - Poolbeg Pharma - First trial site activated in major operational milestone

Poolbeg has announced first site activation for its POLB 001 TOPICAL clinical trial, marking a key operational milestone and transitioning the...

Poolbeg Pharma PLC Preclinical data posters presented at EHA Congress

Poolbeg Pharma PLC 11 June 2026     Poolbeg Pharma plc   Two posters with POLB 001 preclinical data presented at the European Hematology...

Poolbeg Pharma PLC Poolbeg Announces POLB 001 TOPICAL Site Activation

Poolbeg Pharma PLC 11 June 2026     Poolbeg Pharma plc   Poolbeg Pharma Announces Successful Site Activation for POLB 001 TOPICAL Clinical Trial...

Poolbeg Pharma PLC Results of AGM & Change of Registered Address

Poolbeg Pharma PLC 09 June 2026     Poolbeg Pharma plc   Results of AGM & Change of Registered Address     9 June 2026 - Poolbeg...

Cavendish - Morning Note – 26 May 2026